nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CXCL8—AP-1 transcription factor network—CDKN1B—ocular cancer	0.00453	0.00453	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—CDK4—ocular cancer	0.00441	0.00441	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CDK6—ocular cancer	0.00439	0.00439	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—MDM2—ocular cancer	0.00437	0.00437	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00434	0.00434	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—CCND1—ocular cancer	0.00432	0.00432	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—EIF1AX—ocular cancer	0.00431	0.00431	CbGpPWpGaD
Ketoprofen—CXCL8—IL8- and CXCR2-mediated signaling events—AKT1—ocular cancer	0.00428	0.00428	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00426	0.00426	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—RB1—ocular cancer	0.00421	0.00421	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00418	0.00418	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—CDKN2B—ocular cancer	0.00409	0.00409	CbGpPWpGaD
Ketoprofen—ABCC4—Fluoropyrimidine Activity—TP53—ocular cancer	0.00407	0.00407	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—CDK6—ocular cancer	0.00401	0.00401	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—EP300—ocular cancer	0.00398	0.00398	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.00388	0.00388	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SAG—ocular cancer	0.00387	0.00387	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—ocular cancer	0.00384	0.00384	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—RB1—ocular cancer	0.00383	0.00383	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—E2F1—ocular cancer	0.00376	0.00376	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00372	0.00372	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.00368	0.00368	CbGpPWpGaD
Ketoprofen—CXCL8—IL-3 Signaling Pathway—HRAS—ocular cancer	0.00362	0.00362	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—MDM2—ocular cancer	0.00359	0.00359	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.00358	0.00358	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00357	0.00357	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.00351	0.00351	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—MYC—ocular cancer	0.00347	0.00347	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—TGFB1—ocular cancer	0.00346	0.00346	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00346	0.00346	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—RPL39—ocular cancer	0.00344	0.00344	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—GNA11—ocular cancer	0.00343	0.00343	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—E2F5—ocular cancer	0.00342	0.00342	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—E2F4—ocular cancer	0.00335	0.00335	CbGpPWpGaD
Ketoprofen—CXCL8—TSLP Signaling Pathway—AKT1—ocular cancer	0.00331	0.00331	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—RBL1—ocular cancer	0.00329	0.00329	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—CDKN1B—ocular cancer	0.00328	0.00328	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN1B—ocular cancer	0.00328	0.00328	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—CDK2—ocular cancer	0.00324	0.00324	CbGpPWpGaD
Ketoprofen—CXCL8—IL-3 Signaling Pathway—AKT1—ocular cancer	0.0032	0.0032	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—GNAQ—ocular cancer	0.00319	0.00319	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—TGFB1—ocular cancer	0.00314	0.00314	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00312	0.00312	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—GNA11—ocular cancer	0.00311	0.00311	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—CDKN2B—ocular cancer	0.00309	0.00309	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—CDK4—ocular cancer	0.00306	0.00306	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN1A—ocular cancer	0.00302	0.00302	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—CDKN1A—ocular cancer	0.00302	0.00302	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—CDKN1B—ocular cancer	0.00298	0.00298	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—HRAS—ocular cancer	0.00293	0.00293	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—GNAQ—ocular cancer	0.00289	0.00289	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—E2F3—ocular cancer	0.00285	0.00285	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—TP53—ocular cancer	0.00285	0.00285	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—CCND1—ocular cancer	0.00285	0.00285	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—E2F1—ocular cancer	0.00284	0.00284	CbGpPWpGaD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—TGFB1—ocular cancer	0.00278	0.00278	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00278	0.00278	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—RB1—ocular cancer	0.00266	0.00266	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TFDP1—ocular cancer	0.00265	0.00265	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—AKT1—ocular cancer	0.00258	0.00258	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00256	0.00256	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TGFB1—ocular cancer	0.0025	0.0025	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—CDK2—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00244	0.00244	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—TGFB1—ocular cancer	0.00243	0.00243	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—E2F1—ocular cancer	0.00237	0.00237	CbGpPWpGaD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.00232	0.00232	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—CDK4—ocular cancer	0.00231	0.00231	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PSPH—ocular cancer	0.00229	0.00229	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—MYC—ocular cancer	0.00228	0.00228	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TGFB1—ocular cancer	0.00228	0.00228	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—MDM2—ocular cancer	0.00227	0.00227	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.00217	0.00217	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00212	0.00212	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.00212	0.00212	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MAML2—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—EP300—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—CDKN1B—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CDK2—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—RB1—ocular cancer	0.00201	0.00201	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.00197	0.00197	CbGpPWpGaD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—AKT1—ocular cancer	0.00193	0.00193	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CDK4—ocular cancer	0.00193	0.00193	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—GNA11—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—CDKN1A—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TP53—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—GNA11—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—GNAQ—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.00178	0.00178	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SAG—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PSPH—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—MDM2—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CDKN1B—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—GNAQ—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—RB1—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CCND1—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00161	0.00161	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HDAC1—ocular cancer	0.00161	0.00161	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CDKN1A—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Ketoprofen—ABCC4—Ectoderm Differentiation—MYC—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—CDKN1B—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—GNA11—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—E2F5—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HDAC1—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—E2F4—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—EP300—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—TGFB1—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RBL1—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—CDKN1A—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—GNAQ—ocular cancer	0.00144	0.00144	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—GNA11—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PSPH—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CDKN2B—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—EP300—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—MYC—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CDKN1B—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—GNAQ—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—TP53—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—E2F3—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—E2F1—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CCND1—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Ketoprofen—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TFDP1—ocular cancer	0.0012	0.0012	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—CDK2—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PSPH—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PSPH—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—TGFB1—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SAG—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—MYC—ocular cancer	0.001	0.001	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	0.000998	0.000998	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—ocular cancer	0.000984	0.000984	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000974	0.000974	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—E2F5—ocular cancer	0.000967	0.000967	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAML2—ocular cancer	0.000951	0.000951	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—E2F4—ocular cancer	0.000947	0.000947	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RPL39—ocular cancer	0.000929	0.000929	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RBL1—ocular cancer	0.000929	0.000929	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PSPH—ocular cancer	0.000914	0.000914	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000889	0.000889	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—GNA11—ocular cancer	0.000867	0.000867	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000848	0.000848	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GNA11—ocular cancer	0.000829	0.000829	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—ocular cancer	0.000821	0.000821	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00082	0.00082	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—GNAQ—ocular cancer	0.000806	0.000806	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000781	0.000781	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GNAQ—ocular cancer	0.000771	0.000771	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MDM2—ocular cancer	0.000766	0.000766	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000751	0.000751	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TFDP1—ocular cancer	0.000749	0.000749	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HDAC1—ocular cancer	0.000727	0.000727	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GNA11—ocular cancer	0.00072	0.00072	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HRAS—ocular cancer	0.000711	0.000711	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CDKN1B—ocular cancer	0.000699	0.000699	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HDAC1—ocular cancer	0.000695	0.000695	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—AKT1—ocular cancer	0.000692	0.000692	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00068	0.00068	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000679	0.000679	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GNAQ—ocular cancer	0.000669	0.000669	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCND1—ocular cancer	0.000667	0.000667	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CDKN1A—ocular cancer	0.000645	0.000645	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—EP300—ocular cancer	0.00064	0.00064	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—AKT1—ocular cancer	0.000628	0.000628	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN2B—ocular cancer	0.000623	0.000623	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EP300—ocular cancer	0.000614	0.000614	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAML2—ocular cancer	0.000595	0.000595	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—E2F1—ocular cancer	0.000572	0.000572	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000559	0.000559	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TGFB1—ocular cancer	0.000557	0.000557	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GNA11—ocular cancer	0.000547	0.000547	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00054	0.00054	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MYC—ocular cancer	0.000535	0.000535	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TGFB1—ocular cancer	0.000534	0.000534	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—CDK2—ocular cancer	0.000516	0.000516	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GNAQ—ocular cancer	0.000509	0.000509	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000489	0.000489	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000472	0.000472	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—ocular cancer	0.000458	0.000458	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—ocular cancer	0.000439	0.000439	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—ocular cancer	0.000438	0.000438	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HDAC1—ocular cancer	0.000435	0.000435	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNA11—ocular cancer	0.000435	0.000435	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—ocular cancer	0.00042	0.00042	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000411	0.000411	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNAQ—ocular cancer	0.000404	0.000404	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN2B—ocular cancer	0.00039	0.00039	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—AKT1—ocular cancer	0.000387	0.000387	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT1—ocular cancer	0.000371	0.000371	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNA11—ocular cancer	0.000354	0.000354	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNA11—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MDM2—ocular cancer	0.000346	0.000346	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00034	0.00034	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNAQ—ocular cancer	0.000329	0.000329	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNAQ—ocular cancer	0.000327	0.000327	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—ocular cancer	0.000321	0.000321	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN1B—ocular cancer	0.000316	0.000316	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT1—ocular cancer	0.000312	0.000312	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCND1—ocular cancer	0.000301	0.000301	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CDKN1A—ocular cancer	0.000291	0.000291	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—EP300—ocular cancer	0.00029	0.00029	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNA11—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT1—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EP300—ocular cancer	0.000277	0.000277	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TGFB1—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TGFB1—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—EP300—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MDM2—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—ocular cancer	0.000207	0.000207	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN1B—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—EP300—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN1A—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT1—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EP300—ocular cancer	0.000173	0.000173	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT1—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFB1—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKT1—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—EP300—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—EP300—ocular cancer	0.000118	0.000118	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—EP300—ocular cancer	0.000117	0.000117	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKT1—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT1—ocular cancer	0.000105	0.000105	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—EP300—ocular cancer	9.61e-05	9.61e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKT1—ocular cancer	8.77e-05	8.77e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKT1—ocular cancer	7.14e-05	7.14e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKT1—ocular cancer	7.1e-05	7.1e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKT1—ocular cancer	5.81e-05	5.81e-05	CbGpPWpGaD
